ABVC 10-Q: Restatement

ABVC BioPharma

Filed with the SEC on · accession 0001213900-26-118078

ABVC filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -2.0% by the first close after the filing.

Summary of the filing

ABVC BioPharma filed its Q3 2026 10-Q, which includes an error correction and restatement of its statements of operations for the nine months ended September 30, 2025, related to accrued research and development expenses and warrant accounting.

Key details

Accrued research and development expense$1.7M
FilerABVC BioPharma, Inc.
Warrant holder / settlement counterpartyLind

How ABVC stock reacted

Close before

$1.02

Nov 9, 2026

First close after

-1.96%

$1.00

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ABVC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ABVC?

Click here

Frequently asked questions

What did ABVC file with the SEC on Nov 10, 2026?

ABVC filed a 10-Q (Restatement). ABVC BioPharma filed its Q3 2026 10-Q, which includes an error correction and restatement of its statements of operations for the nine months ended September 30, 2025, related to accrued research and development expenses and warrant accounting.

What does a restatement mean for ABVC stock?

The stock often falls sharply. In a Chapter 11 reorganization existing shares are frequently cancelled or heavily diluted; in Chapter 7 the company is liquidated and shareholders are paid last, usually nothing.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ABVC stock react to this filing?

ABVC closed at $1.02 before the filing and $1.00 on Nov 10, 2026 (-1.96%).

Other ABVC SEC filings

Get alerts when ABVC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days